U.S. markets closed
  • S&P 500

    4,185.47
    +15.05 (+0.36%)
     
  • Dow 30

    34,200.67
    +164.68 (+0.48%)
     
  • Nasdaq

    14,052.34
    +13.58 (+0.10%)
     
  • Russell 2000

    2,262.67
    +5.60 (+0.25%)
     
  • Crude Oil

    63.07
    -0.39 (-0.61%)
     
  • Gold

    1,777.30
    +10.50 (+0.59%)
     
  • Silver

    26.04
    +0.08 (+0.29%)
     
  • EUR/USD

    1.1980
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • GBP/USD

    1.3840
    +0.0056 (+0.41%)
     
  • USD/JPY

    108.7830
    +0.0670 (+0.06%)
     
  • BTC-USD

    55,691.74
    -5,122.54 (-8.42%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

Humana (HUM) to Buy Remaining iCare Shares to Expand Medicare

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Humana Inc. HUM recently announced that it will purchase the remaining 50% of iCare, which is a Wisconsin-based healthcare company.

The health insurance giant, which already owns the other half of iCare will buy the residual share from Centers for Independence, Inc. (CFI). Notably, this joint venture dates back to 1994, catering to members in the Wisconsin region via Medicaid and Medicare plans.

However, financial terms of the deal were kept under wraps. The buyout is also subject to certain closing conditions.

iCare serves 44,000 members through Wisconsin’s Medicaid SSI program, BadgerCare program and Medicare D-SNP plans for individuals eligible for both Medicare and Medicaid.

Humana will be able to strengthen its Medicaid business with this transaction. It remains committed to providing quality medical care across Medicare, Medicaid and Commercial product lines in Wisconsin.

With this deal, the company will now be able to provide Medicare D-SNP plans in the state. This buyout will increase Humana’s overall Medicaid membership to more than 730,000 across four states, namely Florida, Illinois, Kentucky and Wisconsin.

As of Sep 30, 2020, Medicaid membership grew 55.7% year over year owing to the transition of the risk for the Kentucky contract from CareSource along with additional enorllment in Florida.

There is a host of initiatives that the company took recently, which helps carving its growth path. Some of the acquisitions made by the company aided it to achieve long-term growth. It also closed the Enclara deal in January, expanding its hospice pharmacy business line.

We expect these initiatives to bode well for the long haul.

Zacks Rank and Price Performance

Shares of this currently Zacks Rank #4 (Sell) company have gained 17% in a year compared with the industry’s growth of 13%.



You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Other companies in the same space, such as Centene Corp. CNC, UnitedHealth Group Incorporated UNH and Anthem Inc. ANTM have also rallied 6.2%, 24.8% and 12.4%, respectively, in the same time frame.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Humana Inc. (HUM) : Free Stock Analysis Report
 
Centene Corporation (CNC) : Free Stock Analysis Report
 
Anthem, Inc. (ANTM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research